This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Zymo Research Corporation. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Xiaojing Yang
Introduction
Xiaojing Yang is a prominent inventor based in Irvine, California. She has made significant contributions to the field of molecular biology, particularly in the area of cancer research. Her work focuses on developing methods to assess DNA methylation, which plays a crucial role in understanding cancer development.
Latest Patents
Xiaojing Yang holds a patent for her innovative work titled "Assays to determine DNA methylation and DNA methylation markers of cancer." This patent outlines methods for determining a genomic methylation profile in a DNA sample. The techniques described can be utilized to assess whether a subject has, or is at risk for developing, bladder cancer or other cancers of the urinary tract. Additionally, the patent provides methods for the treatment of such subjects.
Career Highlights
Xiaojing Yang is currently employed at Zymo Research Corporation, where she continues to advance her research in DNA methylation and its implications in cancer. Her expertise and dedication to her work have positioned her as a valuable asset in the field of cancer diagnostics and treatment.
Collaborations
Throughout her career, Xiaojing has collaborated with notable colleagues, including Wei Guo and Paolo Piatti. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in cancer detection and treatment.
Conclusion
Xiaojing Yang's contributions to the field of cancer research through her innovative patent and collaborative efforts highlight her importance as an inventor. Her work not only advances scientific understanding but also has the potential to improve patient outcomes in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
